BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21947262)

  • 1. [Secondary and tertiary prevention of urological tumors].
    Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
    Urologe A; 2011 Oct; 50(10):1283-7. PubMed ID: 21947262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary prevention after urological cancers. What are the pertinent facts about aftercare?].
    Schroeder A
    Urologe A; 2007 Jun; 46(6):642-5. PubMed ID: 17447048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nutritional prevention of urological tumours].
    Schmitz-Dräger BJ; Sahin S; Lümmen G; Bismarck E; Fischer C;
    Aktuelle Urol; 2014 Jul; 45(4):281-5. PubMed ID: 25166608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention in patients with superficial urothelial carcinoma].
    Schnöller TJ; Zengerling F; Hirning C; Jentzmik F
    Urologe A; 2015 Jul; 54(7):992-7. PubMed ID: 25894992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
    Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
    Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Gender and Age on the Willingness to Reduce Nicotine Consumption-Results of a Survey in Urological Cancer Patients (KRAUT Study).
    Dombrowski M; May M; Spachmann PJ; Ganesh Kumar M; Fritsche HM; Brookman-May S; Maurer O; Burger M; Gilfrich C
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1181-e1187. PubMed ID: 30224329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urological cancer: reduction in the risk of prostate cancer with finasteride.
    Marchesi V
    Nat Rev Clin Oncol; 2013 Nov; 10(11):608. PubMed ID: 23999217
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of bladder cancer incidence and recurrence: nutrition and lifestyle.
    Fankhauser CD; Mostafid H
    Curr Opin Urol; 2018 Jan; 28(1):88-92. PubMed ID: 29211694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Alpha-reductase inhibitors in diseases of the prostate.
    Carrasquillo RJ; Nealy SW; Wang DS
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):488-92. PubMed ID: 25268733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention strategies for prostate cancer.
    Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C
    Minerva Urol Nefrol; 2012 Dec; 64(4):225-31. PubMed ID: 23288209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [De novo urologic tumors in kidney transplant patients].
    Rodríguez Faba O; Breda A; Gausa L; Palou J; Villavicencio H
    Actas Urol Esp; 2015 Mar; 39(2):122-7. PubMed ID: 24996779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of tomato and soy products for men with recurring prostate cancer and rising prostate specific antigen.
    Grainger EM; Schwartz SJ; Wang S; Unlu NZ; Boileau TW; Ferketich AK; Monk JP; Gong MC; Bahnson RR; DeGroff VL; Clinton SK
    Nutr Cancer; 2008; 60(2):145-54. PubMed ID: 18444145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
    Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
    Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary prevention of urologic tumors: prostate cancer].
    Schmitz-Dräger BJ; Lümmen G; Bismarck E; Fischer C;
    Urologe A; 2011 Oct; 50(10):1271-2, 1274-5. PubMed ID: 21927877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor.
    Shiota M; Kiyoshima K; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Takahashi R; Inokuchi J; Tatsugami K; Eto M
    J Urol; 2017 Feb; 197(2):308-313. PubMed ID: 27506696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemoprophylaxis of superficial tumors of the bladder with bleomycin].
    Severini G; Maver P; Benati A; De Vinci C; Mannini D; Romagnoli P
    Minerva Urol Nefrol; 1986; 38(2):141-5. PubMed ID: 2428119
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostatic recurrences in the management of superficial bladder tumors.
    Lockhart JL; Chaikin L; Bondhus MJ; Politano VA
    J Urol; 1983 Aug; 130(2):256-7. PubMed ID: 6410083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic effect of UFT on the recurrence of bladder cancer].
    Naito K; Hisazumi H; Saka A; Nakamura T; Kanda S; Mikawa I; Ejiri S; Miyagi T; Katsumi T; Kitagawa K
    Hinyokika Kiyo; 1990 Apr; 36(4):487-94. PubMed ID: 2116083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: do we have the evidence from intervention studies?
    Ellinger S; Ellinger J; Stehle P
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):722-7. PubMed ID: 17053426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.